FinTrust Capital Advisors’s Takeda Pharmaceutical TAK Stock Holding History

FinTrust Capital Advisors’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$6.73K	Sell	473 -77	-14%	-$1.09K	﹤0.01%	1025
2024 Q2	$7.12K	Buy	550 +147	+36%	+$1.95K	﹤0.01%	970
2024 Q1	$5.6K	Sell	403 -118	-23%	-$1.72K	﹤0.01%	967
2023 Q4	$7.43K	Hold	521	–	–	﹤0.01%	883
2023 Q3	$8.06K	Sell	521 -114	-18%	-$1.76K	﹤0.01%	817
2023 Q2	$9.91K	Hold	635	–	–	﹤0.01%	771
2023 Q1	$9.91K	Hold	635	–	–	﹤0.01%	769
2022 Q4	$9.91K	Sell	635 -15	-2%	-$210	﹤0.01%	766
2022 Q3	$8K	Hold	650	–	–	﹤0.01%	940
2022 Q2	$9K	Hold	650	–	–	﹤0.01%	921
2022 Q1	$10K	Sell	650 -177	-21%	-$2.6K	﹤0.01%	954
2021 Q4	$11K	Sell	827 -120	-13%	-$1.68K	﹤0.01%	903
2021 Q3	$16K	Sell	947 -11	-1%	-$185	﹤0.01%	797
2021 Q2	$16K	Sell	958 -89	-9%	-$1.51K	﹤0.01%	812
2021 Q1	$19K	Hold	1,047	–	–	0.01%	736
2020 Q4	$19K	Buy	1,047 +193	+23%	+$3.39K	0.01%	697
2020 Q3	$15K	Hold	854	–	–	﹤0.01%	716
2020 Q2	$15K	Sell	854 -99	-10%	-$1.78K	0.01%	678
2020 Q1	$14K	Sell	953 -234	-20%	-$4.24K	0.01%	701
2019 Q4	$23K	Buy	1,187 +61	+5%	+$1.17K	0.01%	607
2019 Q3	$19K	Buy	1,126 +68	+6%	+$1.18K	0.01%	665
2019 Q2	$19K	Sell	1,058 -157	-13%	-$2.86K	0.01%	621
2019 Q1	$25K	Buy	1,215 +468	+63%	+$9.42K	0.01%	547
2018 Q4	$13K	Buy	+747	New	+$12.6K	0.01%	708

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

FinTrust Capital Advisors's TAK Position: Q3 2024 in Review

FinTrust Capital Advisors reduced its Takeda Pharmaceutical (TAK) stake by 14% in Q3 2024, selling an estimated $1.09K and leaving 473 shares worth $6.73K. The position accounts for ﹤0.01% of the portfolio, ranked #1025.

FinTrust Capital Advisors first reported a position in TAK in Q4 2018 and has held it in 24 quarters since. The position peaked at $25K in Q1 2019. 299 funds tracked by Wall St. Rank hold TAK as of Q3 2024.

FinTrust Capital Advisors held 473 shares of Takeda Pharmaceutical worth $6.73K as of Q3 2024.
FinTrust Capital Advisors sold 77 Takeda Pharmaceutical shares in Q3 2024, an estimated $1.09K.
Takeda Pharmaceutical made up ﹤0.01% of FinTrust Capital Advisors's portfolio in Q3 2024, its #1025 holding.
FinTrust Capital Advisors first reported a position in Takeda Pharmaceutical in Q4 2018 and has held it in 24 quarters since.
FinTrust Capital Advisors's Takeda Pharmaceutical position peaked at $25K in Q1 2019.
299 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.